Bulletin
Investor Alert

press release

July 19, 2022, 6:30 a.m. EDT

Sage Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 2, 2022

CAMBRIDGE, Mass., (BUSINESS WIRE) -- Sage Therapeutics, Inc. /zigman2/quotes/200179567/composite SAGE +1.48% , a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, August 2, 2022 at 8:00 a.m. ET to announce second quarter 2022 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com . A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20220718005799/en/

SOURCE: Sage Therapeutics, Inc.

Investor
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.com

Media
Becky Kern
914-772-2310
becky.kern@sagerx.com

COMTEX_410507769/2456/2022-07-19T06:30:04

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2022

/zigman2/quotes/200179567/composite
US : U.S.: Nasdaq
$ 38.48
+0.56 +1.48%
Volume: 534,259
Nov. 29, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$2.26 billion
Rev. per Employee
$13,724
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.